• Product NameRecombinant Human ALG12
• Brief DescriptionRecombinant Protein
• Immunogen DescriptionFusion protein corresponding to a region derived from 367-488 amino acids of human ALG12, alpha-1,6-mannosyltransferase
• Target NameALG12, alpha-1,6-mannosyltransferase
• Alternative Names    CDG1G; ECM39; hALG12; PP14673
• Accession No. Swissprot:Q9BV10
  Gene Accession:BC001729
• UniprotQ9BV10
• Gene ID79087;
• Storage -20~-80˚C, pH 7.6 PBS

This gene encodes a member of the glycosyltransferase 22 family. The encoded protein catalyzes the addition of the eighth mannose residue in an alpha-1,6 linkage onto the dolichol-PP-oligosaccharide precursor (dolichol-PP-Man(7)GlcNAc(2)) required for protein glycosylation. Mutations in this gene have been associated with congenital disorder of glycosylation type Ig (CDG-Ig)characterized by abnormal N-glycosylation.

Note: For in vitro research use only, not for diagnostic or therapeutic use. This product is not a medical device.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting